Going to this morning's Targeted Therapy Frontiers in MSS Metastatic Colorectal Cancer session at #AACR26? Read "Clinical Validity of FoundationOne Liquid CDx for Detection of BRAFV600E in Colorectal Cancer," by session speaker Scott Kopetz: https://t.co/CM6EMuFTfE
@skopetz @AACR https://t.co/1iYQNZ6t03